Clinical Trials in Philadelphia

Showing 12521-12540 of 20,904 trials

Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)

NCT03088956

The objectives of the study are to; (1) estimate the change in disease -related cognitive decline over 1 year on a battery of cognitive tests administered to participants with early-stage symptomatic Behavioral Variant Frontotemporal Dementia (bvFTD) phenotypic variant; (2) identify the cognitive test or brief battery of cognitive tests which are the most sensitive to detect bvFTD progression; (3) determine the optimal schedule of administration of cognitive tests to detect bvFTD progression; (4) evaluate the relationship between cognitive tests and measures of behavior, function, caregiver's burden, quality of life (QOL); and (5) obtain blood samples for genetic and exploratory biomarkers correlations.

Frontotemporal DementiaBehavioral Variant Frontotemporal Dementia

Biogen47 participantsStarted Jan 2018

Birmingham, Alabama, United States • Los Angeles, California, United States • Boca Raton, Florida, United States +9 more locations

COMPLETEDPhase 2< 1 mile

A Gene Therapy Study for Hemophilia B

NCT02484092

A Phase 1/2, Open-Label, Non-Randomized, Dose-Escalation Study of SPK-9001 in Subjects with Hemophilia B.

Hemophilia B

Pfizer15 participantsStarted Nov 2015

Sacramento, California, United States • Sacramento, California, United States • Sacramento, California, United States +7 more locations

Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)

A Gene Therapy Study for Hemophilia B

Find Trials by Condition in Philadelphia

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF

Incentivizing Reflection and Output in Exercise

Enduring Exercise Habits: Trending Norms

Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH

Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation

A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis

A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis

LAM Pilot Study With Imatinib Mesylate

Self-Management App for Patients With Left-Ventricular Assist Devices

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

GSK2982772 Study in Subjects With Ulcerative Colitis

A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis

Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections

Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events

Measurement of NonInvasive Blood Pressure in Neonates Through Adults and Special Populations

Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease